Product Description
Epratuzumab (CD22) Antibody, Monoclonal | 10-073 | ProSci
Host: N/A
Reactivity: N/A
Homology: N/A
Immunogen: Humanized / CD22 [Homo sapiens]
Research Area: Drug Analogues
Tested Application: N/A
Application: N/A
Specificiy: N/A
Positive Control 1: N/A
Positive Control 2: N/A
Positive Control 3: N/A
Positive Control 4: N/A
Positive Control 5: N/A
Positive Control 6: N/A
Molecular Weight: N/A
Validation: N/A
Isoform: N/A
Purification: >95%
Clonality: Monoclonal
Clone: N/A
Isotype: IgG1-nd
Conjugate: Unconjugated
Physical State: N/A
Buffer: PBS buffer pH7.5
Concentration: N/A
Storage Condition: Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚C for 1-2 weeks. Store at -20 ˚C for 12 months. Store at -80 ˚C for long term storage.
Alternate Name: 90Y-DOTA-hLL2, 90Y-epratuzumab tetraxetan, AMG-412, 90Y-hLL2, hLL2, CD22, CD22
User Note: Optimal dilutions for each application to be determined by the researcher.
BACKGROUND: Epratuzumab is a humanized monoclonal antibody derived from the murine IG2a monoclonal antibody, LL2 (EPB-2) .This agent may subsequently be well matched for use in oncology and the treatment of inflammatory autoimmune disorders, such as lupus.